Loss of p53 in CRaf-induced transgenic lung adenoma leads to tumor acceleration and phenotypic switch

Cancer Research

Volumn 63, Issue 9, 2003, Pages 2268-2277

  Fedorov, Lev M ^a   Papadopoulos, Thomas ^b   Tyrsin, Oleg Y ^a   Twardzik, Thomas ^a   Götz, Rudolf ^a   Rapp, Ulf R ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE MARKER; PROTEIN C; PROTEIN P21; PROTEIN P53; PROTEIN SERINE THREONINE KINASE; RAF PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL SHAPE; CELL STRUCTURE; CLARA CELL; CONTROLLED STUDY; GENE LOSS; GENE SWITCHING; GENE TARGETING; LATENT PERIOD; LUNG ADENOMA; LUNG CARCINOGENESIS; METASTASIS; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEPLETION; TARGET CELL; TRANSGENIC MOUSE; TUMOR DIFFERENTIATION;

ADENOCARCINOMA; ADENOMA; ALLELES; ANIMALS; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; GENE DELETION; GENES, P53; GENES, SWITCH; LUNG NEOPLASMS; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; PROTO-ONCOGENE PROTEINS C-RAF;

EID: 0038036832     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Ginsberg, R. E., Vokes, E., and Rosenzweig, K. Non-small cell lung cancer. In: V. T. DeVita, S. Hellman, and S. A. Rosenberg (eds.), Cancer: Principles and practice of oncology, Sixth Ed., pp. 925-983. Philadelphia: Lippincott Williams & Wilkins, 2001.
2. Kerr, K. M. Pulmonary preinvasive neoplasia. J. Clin. Pathol., 54: 257-271, 2001.
3. Dungworth, D. L., Rittinghausen, S., Schwartz, L., Harkema, J. R., Hayashi, Y., Kittel, B., Lewis, D., Miller, R. A., Mohr, U., Morgan, K. T., Rehm, S., and Slayter, M. V. Respiratory system and mesothelium. In: U. Mohr (ed.), International Classification of Rodent Tumors. The Mouse, pp. 116-131. Heidelberg, Berlin, New York: Springer Verlag, 2001.
4. Niklinska, W., Chyczewski, L., and Niklinski, J. New molecular approaches to lung cancer: biological and clinical implications of P53. P16 and K-RAS studies. Folia Histochem. Cytobiol., 39: 99-103, 2001.
5. Salgia, R., and Skarin, A. T. Molecular abnormalities in lung cancer. J. Clin. Oncol., 16: 1207-1217, 1998.
6. Forgacs, E., Zochbauer-Muller, S., Olah, E., and Minna, J. D. Molecular genetic abnormalities in the pathogenesis of human lung cancer. Pathol. Oncol. Res., 7: 6-13, 2001.
7. Rapp, U. R., Huleihel, M., Pawson, A., Minna, J. D., Fanning-Heidecker, G., Cleveland, J. L., Beck, T., Forchhammer, J., and Storm, S. M. Role of raf oncogenes in lung carcinogenesis. Lung Cancer, 4: 162-167, 1988.
8. Reed, J. C., Yum, S., Cuddy, M. P., Turner, B. C., and Rapp, U. R. Differential regulation of the p72-74 RAF-1 kinase in 3T3 fibroblasts expressing ras or src oncogenes. Cell Growth Differ., 2: 235-243, 1991.
9. Davies, H., Bignell, G. R., Cox, C., Stephens, P., Edkins, S., Clegg, S., Teague, J., Woffendin, H., Garnett, M. J., Bottomley, W., Davis, N., Dicks, E., Ewing, R., Floyd, Y., Gray, K., Hall, S., Hawes, R., Hughes, J., Kosmidou, V., Menzies, A., Mould, C., Parker, A., Stevens, C., Watt, S., Hooper, S., Wilson, R., Jayatilake, H., Gusterson, B. A., Cooper, C., Shipley, J., Hargrave, D., Pritchard-Jones, K., Maitland, N., Chenevix-Trench, G., Riggins, G. J., Bigner, D. D., Palmieri, G., Cossu, A., Flanagan, A., Nicholson, A., Ho, J. W., Leung, S. Y., Yuen, S. T., Weber, B. L., Seigler, H. F., Darrow, T. L., Paterson, H., Marais, R., Marshall, C. J., Wooster, R., Stratton, M. R., and Futreal, P. A. Mutations of the BRAF gene in human cancer. Nature (Lond.), 417: 949-954, 2002.
10. Rajagopalan, H., Bardelli, A., Lengauer, C., Kinzler, K. W., Vogelstein, B., and Velculescu, V. E. Tumorigenesis: RAF/RAS oncogenes and mismatch-repair status. Nature (Lond.), 418: 934, 2002.
11. Kerkhoff, E., Fedorov, L. M., Siefken, R., Walter, A. O., Papadopoulus, T., and Rapp, U. R. Lung-targeted expression of the c-Raf-1 kinase in transgenic mice exposes a novel oncogenic character of the wild-type protein. Cell Growth Diff., 11: 185-190, 2000.
12. Baumann, B., Weber, C. K., Troppmair, J., Whiteside, S., Israel, A., Rapp, U. R., and Wirth, T. Raf induces NF-κB by membrane shuttle kinase MEKK1, a signaling pathway critical for transformation. Proc. Natl. Acad. Sci. USA, 97: 4615-4620, 2000.
13. Wang, H. G., Miyashita, T., Takayama, S., Sato, T., Torigoe, T., Krajewski, S., Tanaka, S., Hovey, L., III, Troppmair, J., and Rapp, U. R. Apoptosis regulation by interaction of Bcl-2 protein and Raf-1 kinase. Oncogene, 9: 2751-2756, 1994.
14. Wang, H. G., Rapp, U. R., and Reed, J. C. Bcl-2 targets the protein kinase Raf-1 to mitochondria. Cell, 87: 629-638, 1996.
15. Wang, H. G., Takayama, S., Rapp, U. R., and Reed, J. C. Bcl-2 interacting protein. BAG-1, binds to and activates the kinase Raf-1. Proc. Natl. Acad. Sci. USA, 93: 7063-7068, 1996.
16. Rapp, U. R., and Troppmair, J. Dominant oncogenes as cancer candidates: role of Raf kinases and Myc, two master regulators of phenotypic and genomic stability. In: A. Rosenthal, U. Wahn, and H. Wolf (eds.), Einfluß von Genomprojekt und Pharmacogentics auf die medizinische Entwicklung, pp. 25-42. Stuttgart: Schattauer, 2002.
17. Fedorov, L. M., Papadopoulos, T., Tyrsin, O. Y., Götz, R., and Rapp, U. R. Bcl-2 determines susceptibility to induction of lung cancer by oncogenic CRaf. Cancer Res., 62: 6297-6303, 2002.
18. Hotte, S. J., and Hirte, H. W. BAY43-9006: Early clinical data in patients with advanced solid malignancies. Curr. Pharm. Des., 8: 2249-2253, 2002.
19. Lau, Q. C., Brusselbach, S., and Muller, R. Abrogation of c-Raf expression induces apoptosis in tumor cells. Oncogene, 16: 1899-1902, 1998.
20. Zhong, J., Troppmair, J., and Rapp, U. R. Independent control of cell survival by Raf-1 and Bcl-2 at the mitochondria. Oncogene, 20: 4807-4816, 2001.
21. Le Mellay, V., Houben, R., Troppmair, J., Hagemann, C., Mazurek, S., Frey, U., Beigel, J., Weber, C., Benz, R., Eigenbrodt, E., and Rapp, U. R. Regulation of glycolysis by Raf protein serine/threonine kinases. Adv. Enzyme Regul., 42: 317-332, 2002.
22. Kerkhoff, E., and Rapp, U. R. Cell cycle targets of Ras/Raf signalling. Oncogene, 17: 1457-1462, 1998.
23. Kerkhoff, E., and Rapp, U. R. High-intensity Raf signals convert mitotic cell cycling into cellular growth. Cancer Res., 58: 1636-1640, 1998.
24. Jacks, T., Remington, L., Williams, B. O., Schmitt, E. M., Halachmi, S., Bronson, R. T., and Weinberg, R. A. Tumor spectrum analysis in p53-mutant mice. Curr. Biol., 4: 1-7, 1994.
25. CIPI/WAFI undergo normal development, but are defective in G1 checkpoint control. Cell, 82: 675-684, 1995.
26. Suzuki, K., Nagai, K., Yoshida, J., Nishimura, M., Takahashi, K., Yokose, T., and Nishiwaki, Y. Conventional clinicopathologic prognostic factors in surgically resected nonsmall cell lung carcinoma. A comparison of prognostic factors for each pathologic TNM stage based on multivariate analyses. Cancer (Phila.), 86: 1976-1984, 1999.
27. Zsengeller, Z. K., Wert, S. E., Bachurski, C. J., Kirwin, K. L., Trapnell, B. C., and Whitsett, J. A. Recombinant adenoviral vector disrupts surfactant homeostasis in mouse lung. Hum. Gene Ther., 8: 1331-1344, 1997.
28. Yaffe, D., and Saxel, O. A myogenic cell line with altered serum requirements for differentiation. Differentiation, 7: 159-166, 1977.
29. Wikenheiser, K. A., Clark, J. C., Linolla, I., Stahlman, M. T., and Whitsett, J. A. Simian virus 40 large T antigen directed by transcriptional elements of the human surfactant protein C gene produces pulmonary adenocarcinomas in transgenic mice. Cancer Res., 52: 5342-5352, 1992.
30. Wert, S. E., Glasser, S. W., Korfhagen, T. R., and Whitsett, J. A. Transcriptional elements from the human SP-C gene direct expression in the primordial respiratory epithelium of transgenic mice. Dev. Biol., 156: 426-443, 1993.
31. Wuenschell, C. W., Sunday, M. E., Singh, G., Minoo, P., Slavkin, H. C., and Warburton, D. Embryonic mouse lung epithelial progenitor cells co-express immunohistochemical markers of diverse mature cell lineages. J. Histochem. Cytochem., 44: 113-123, 1996.
32. Kinzler, K. W., and Vogelstein, B. Lessons from hereditary colorectal cancer. Cell, 87: 159-170, 1996.
33. Hanahan, D., and Weinberg, R. A. The hallmarks of cancer. Cell, 100: 57-70, 2000.
34. Malkinson, A. M. Molecular comparison of human and mouse pulmonary adenocarcinomas. Exp. Lung Res., 24: 541-555, 1998.
35. Rapp, U. R., Cleveland, J. L., Storm, S. M., Beck, T. W., and Huleihel, M. Transformation by raf and myc oncogenes. Princess Takamatsu Symp., 17: 55-74, 1986.
36. Rapp, U. R., Cleveland, J. L., Bonner, T. I., and Storm, S. M. The raf oncogene family. In: T. Curran, E. P. Reddy, and A. Skalka (eds.), The Oncogene Handbook, pp. 213-253, Amsterdam; Elsevier, 1988.
37. McCormick, F. Signal transduction - why Ras needs Rho. Nature (Lond.), 394: 220-221, 1998.
38. Bar-Sagi, D., and Hall, A. Ras and Rho GTPases: a family reunion. Cell, 103: 227-238, 2000.
39. Liotta, L. A., and Kohn, E. C. The microenvironment of the tumour-host interface. Nature (Lond.), 411: 375-379, 2001.
40. Gastl, G., Ward, J. M., and Rapp, U. R. Immunocytochemistry of oncogenes. In: J. M. Polak and S. Van Norden (eds.), Immunohistochemistry, Modern Methods and Aapplications, Second Ed., pp. 273-283. Bristol: John Wright & Sons, 1986.
41. Rapp, U. R., Cleveland, J. L., Fredrickson, T. N., Holmes, K. L., Morse, H. C., III, Jansen, H. W., Patschinsky, T., and Bister, K. Rapid induction of hemopoietic neoplasms in newbom mice by a raf(mil)/myc recombinant murine retrovirus. J. Virol., 55: 23-33, 1985.
42. Klinken, S. P., Rapp, U. R., and Morse, H. C., III raf/myc-infected erythroid cells are restricted in their ability to terminally differentiate. J. Virol., 63: 1489-1492, 1989.
43. Rapp, U. R., Goldsborough, M. D., Mark, G. E., Bonner, T. I., Groffen, J., Reynolds, F. H., Jr., and Stephenson, J. R. Structure and biological activity of v-raf, a unique oncogene transduced by a retrovirus. Proc. Natl. Acad. Sci. USA, 80: 4218-4222, 1983.
44. Rapp, U. R., Reynolds, F. H., Jr., and Stephenson, J. R. New mammalian transforming retrovirus: demonstration of a polyprotein gene product. J. Virol., 45: 914-924, 1983.
45. Blasi, E., Mathieson, B. J., Varesio, L., Cleveland, J. L., Borchert, P. A., and Rapp, U. R. Selective immortalization of murine macrophages from fresh bone marrow by a raf/myc recombinant murine retrovirus. Nature (Lond.), 318: 667-670, 1985.
46. Hilbert, D. M., Pumphrey, J. G., Troppmair, J., Rapp, U. R., and Rudikoff, S. Susceptibility and resistance to J3V1 retrovirus-induced murine plasmacytomagenesis in reconstituted severe combined immunodeficient mice. Oncogene, 8: 1993-2000, 1993.
47. Hilbert, D. M., Shen, M-Y., Rapp, U. R., and Rudikoff, S. T. T cells induce terminal differentiation of transformed B cells to mature plasma cell tumors. Proc. Natl. Acad. Sci. USA, 92: 649-653, 1995.
48. Klinken, S. P., Alexander, W. S., and Adams, J. M. Hemopoietic lineage switch: v-raf oncogene converts Emu-myc transgenic B cells into macrophages. Cell, 53: 857-867, 1988.
49. Principato, M., Klinken, S. P., Cleveland, J. L., Rapp, U. R., Holmes, K. L., Pierce, J. H., and Morse, H. C., III. In vitro transformation of murine bone marrow cells with a v-raf/v-myc retrovirus yields clonally related mature B cells and macrophages. Curr. Top. Microbiol. Immunol., 141: 31-41, 1988.
50. Principato, M., Cleveland, J. L., Rapp, U. R., Holmes, K. L., Pierce, J. H., Morse, H. C., III, and Klinken, S. P. Transformation of murine bone marrow cells with combined v-raf-v-myc oncogenes yields clonally related mature B cells and macrophages. Mol. Cell. Biol., 10: 3562-3568, 1990.
51. Morse, H. C., III, and Rapp, U. R. Tumorigenic activity of artificially activated oncogenes. In: G. Klein (ed.), Cellular Oncogene Activation, pp. 335-364. New York: Marcel Dekker, 1988.
52. Borzillo, G. V., Ashmun, R. A., and Sherr, C. J. Macrophage lineage switching of murine early pre-B lymphoid cells expressing transduced fms genes. Mol. Cell. Biol., 10: 2703-2714, 1990.
53. Busslinger, M., Nutt, S. L., and Rolink, A. G. Lineage commitment in lymphopoiesis. Curr. Opin. Immunol., 12: 151-158, 2000.
54. Wikenheiser, K. A., and Whitsett, J. A. Tumor progression and cellular differentiation of pulmonary adenocarcinomas in SV40 large T antigen transgenic mice. Am. J. Respir. Cell Mol. Biol., 16: 713-723, 1997.
55. Sunday, M. E., Haley, K. J., Sikorski, K., Graham, S. A., Emanuel, R. L., Zhang, F., Mu, Q., Shahsafaei, A., and Hatzis, D. Calcitonin driven v-Ha-ras induces multilineage pulmonary epithelial hyperplasias and neoplasms. Oncogene, 18: 4336-4347, 1999.
56. Sherr, C. J. Tumor surveillance via the ARF-p53 pathway, Genes Dev., 12: 2984-2991, 1998.